DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.6230
-0.0328 (-5.00%)
At close: Mar 28, 2025, 4:00 PM
0.6315
+0.0084 (1.36%)
After-hours: Mar 28, 2025, 7:17 PM EDT

Company Description

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.

Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems.

It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services.

The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.

DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Corp.
DarioHealth logo
Country United States
Founded 2011
Industry Health Information Services
Sector Healthcare
Employees 202
CEO Erez Raphael

Contact Details

Address:
322 W 57th St, #33B
New York, New York 10019
United States
Website dariohealth.com

Stock Details

Ticker Symbol DRIO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001533998
CUSIP Number 23725P209
ISIN Number US23725P2092
Employer ID 45-2973162
SIC Code 3841

Key Executives

Name Position
Erez Raphael Chief Executive Officer and Director
Zvi Ben David CPA Chief Financial Officer, Treasurer and Secretary
Tomer Ben-Kiki Chief Technology Officer
Steven C. Nelson Chief Commercial Officer
Dov Oppenheim Co-Founder and Production Chief
Lara Dodo Chief Operations Officer
Kat Parrella Investor Relations Manager
Mona Dean Chief Compliance Officer
Claudia Levi Content and Communications Manager
Limor Drezner Chief People Officer

Latest SEC Filings

Date Type Title
Mar 19, 2025 8-K Current Report
Mar 14, 2025 8-K Current Report
Mar 10, 2025 DEF 14A Other definitive proxy statements
Mar 10, 2025 10-K Annual Report
Mar 6, 2025 SCHEDULE 13G Filing
Feb 28, 2025 PRE 14A Other preliminary proxy statements
Feb 27, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 12, 2025 SCHEDULE 13G/A Filing
Feb 12, 2025 SCHEDULE 13G/A Filing